Caralluma fimbriata
Caralluma fimbriata · Accepted scientific name
Scientific literature: Very Sparse (6 studies) · ★☆☆☆☆
Caralluma fimbriata is a remarkable medicinal plant recognized for its diverse pharmacological activities, including antioxidant, antiarthritic, anticancer, and hepatoprotective properties. This plant is rich in bioactive chemical compounds such as flavonoids, glycosides, and tannins, which contribute to its therapeutic potential. Research focuses on various preparations, including the whole plant as well as ethanolic and hydro-alcoholic extracts of Caralluma fimbriata (CFE). These extracts are studied for their ability to address complex health conditions like metabolic syndrome, high blood pressure, and arthritis. Furthermore, the plant has gained significant attention for its ability to help manage appetite and support overall metabolic health.
- Synonyms
- Ceropegia Adscendens Var. Fimbriata · Caralluma Adscendens Var. Fimbriata
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Caralluma fimbriata is a plant species that is frequently identified by several different botanical names. Within taxonomic literature, it is often recognized by the synonym Caralluma adscendens var. fimbriata. Researchers also classify this specimen under the alternative name Ceropegia adscendens var. fimbriata. These various nomenclatural relationships can sometimes cause confusion for enthusiasts and botanists alike. Understanding these synonyms is essential for ensuring accurate identification and documentation in scientific studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Caralluma fimbriata is a unique member of the kingdom Plantae that showcases the intricate diversity of the natural world. Within this vast kingdom, the species is classified under the class Equisetopsida. It belongs to the specific genus Caralluma, a group known for its distinct morphological traits. This plant is further categorized under the order Gentianales, placing it among a specialized lineage of flowering plants. Ultimately, its botanical journey leads it to the family Apocynaceae, where it shares common characteristics with many other succulent species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Caralluma |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Caralluma fimbriata is a plant species primarily found within the tropical regions of Asia. Its natural distribution spans across the Indian Subcontinent, including significant populations in India and Sri Lanka. Additionally, the species extends its reach into the Indo-China region, specifically within Myanmar. These diverse geographical locations highlight the plant's adaptability to various tropical environments. Understanding these specific habitats is essential for studying its ecological role across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Caralluma fimbriata is a versatile medicinal plant recognized for its wide range of significant therapeutic activities. Research indicates that the plant possesses potent antioxidant properties, which contribute to its overall health-ameliorating effects. Studies have specifically highlighted its antiarthritic potential, demonstrating its ability to reduce inflammation and preserve joint integrity. Furthermore, the plant exhibits hypolipidemic, hepatoprotective, and anticancer activities, making it a promising candidate for managing complex metabolic conditions. These diverse bioactive constituents position this neglected succulent as an invaluable resource in the development of functional foods and nutraceuticals.
Compounds
Caralluma fimbriata is a traditional medicinal plant recognized for its diverse array of bioactive constituents. Research indicates that this plant contains essential phytochemicals such as flavonoids, which contribute to its therapeutic properties. In addition to these, the plant is known to contain glycosides that play a role in its complex chemical profile. The presence of tannins further enhances the biological potential of its various extracts. Together, these compounds likely underpin the significant antioxidant and anti-inflammatory activities observed in the species.
Conditions
Caralluma fimbriata serves as a valuable medicinal plant for treating metabolic syndrome by mitigating its various risk factors. It effectively treats abnormal cholesterol levels, including hypercholesterolemia and imbalances in HDL, LDL, and VLDL. The plant also treats alterations in the activities of enzymes of lipid metabolism, helping to restore normal lipid profiles. Additionally, it treats alterations related to carbohydrate metabolism by regulating glycogen content and key metabolic enzymes. Finally, Caralluma fimbriata treats alterations related to lipid metabolism that occur under high calorie diet consumption.
Preparations
Caralluma fimbriata is prepared as an ethanolic extract to evaluate its significant antiarthritic, antioxidant, and anti-inflammatory potential. In studies focusing on metabolic regulation, the plant is prepared as a hydro-alcoholic extract of Caralluma fimbriata (CFE) to mitigate alterations in lipid and carbohydrate metabolism. This hydroalcoholic extract of Caralluma fimbriata (CFE) has demonstrated the ability to restore glycogen levels and key enzyme activities in high-fat diet-induced models. Furthermore, the plant is prepared as whole plants for the isolation and structural elucidation of novel pregnane glycosides. These various preparation methods allow for the exploration of the plant's diverse bioactive constituents and therapeutic applications.